Screening to prevent osteoporotic fractures in Egypt: a position statement of the Egyptian Academy of Bone Health

被引:2
|
作者
El Miedany, Yasser [1 ]
El Gaafary, Maha [2 ]
Gadallah, Naglaa [3 ]
Mahran, Safaa [4 ]
Abu-Zaid, Mohamed Hassan [5 ]
Hassan, Waleed [6 ]
Elwakil, Walaa [7 ]
机构
[1] Canterbury Christ Church Univ, Canterbury, England
[2] Ain Shams Univ, Community & Publ Hlth, Cairo, Egypt
[3] Ain Shams Univ, Rheumatol & Rehabil, Cairo, Egypt
[4] Assiut Univ, Phys Med Rheumatol & Rehabil, Assiut, Egypt
[5] Tanta Univ, Rheumatol & Rehabil, Tanta, Egypt
[6] Benha Univ, Rheumatol & Rehabil, Banha, Egypt
[7] Alexandria Univ, Phys Med Rheumatol & Rehabil, Alexandria, Egypt
关键词
Osteoporosis; Egypt; Primary prevention; Secondary prevention; FRAX; DXA; Fractures; Position statement; Egyptian Academy of Bone Health;
D O I
10.1186/s43166-024-00240-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundBy 2030, approximately 22.6 million individuals in Egypt will be older than 50 years and prone to develop osteoporosis and are at risk of sustaining a fragility fracture. Osteoporotic fragility fractures, and in particular hip fractures, are associated with enduring pain, physical disability, poor quality of life, and loss of independence. Mortality rates are also high in this cohort of patients. Over the coming years, the potential preventable burden is likely to surge, particularly with the aging of the Egyptian population. The aim of this work was to determine the age onset of screening for risk of fragility fracture among Egyptians.ResultsA convincing evidence was found that fracture risk assessments are accurate and can be applicable in standard practice to identify individuals at high/very high risk of developing fragility fractures. A tremendous increase in the risk of fragility fracture at the age of 60 (RR = 33.5 for men and 20.2 for women). As interventions to either treat osteoporosis or to modify behavioral risk factors in terms of healthy eating and physical exercise would take years to change this risk, it was recommended to start screening for fragility fracture at the age of 50 for both men and women.ConclusionAll Egyptian men and postmenopausal women 50 years of age or older should be evaluated/screened for their risk of sustaining a fragility fracture risk. The consequences of failing to identify and treat women and men who are prone to sustain a fragility fracture are considerable. In contrast to DXA scanning, screening with FRAX is cost-effective (time and effort required by patients and the health care system).
引用
收藏
页数:6
相关论文
共 43 条
  • [21] Egyptian consensus on treat-to-target approach for osteoporosis: a clinical practice guideline from the Egyptian Academy of bone health and metabolic bone diseases
    Yasser El Miedany
    Mohammed Hassan Abu-Zaid
    Maha El Gaafary
    Mona Mansour Hasab El Naby
    Nihal Fathi
    Heba Gamal Saber
    Waleed Hassan
    Mervat Eissa
    Nevine Mohannad
    Henaz Khaled
    Mohamed Mortada
    Samah Ismail Nasef
    Salwa Galal
    Rasha Ghaleb
    Samar Abd Alhamed Tabra
    Sally S. Mohamed
    Basma M. Medhat
    Hany M. Aly
    Gehan Elolemy
    Nermeen Ahmed Fouad
    Sahar S. Ganeb
    Yasmin Adel
    Medhat Mohiy Eldin Ibrahim
    Osama Farouk
    Naglaa Gadallah
    Egyptian Rheumatology and Rehabilitation, 2021, 48
  • [22] Acceptability of screening to prevent osteoporotic fractures: a qualitative study with older women
    Emmett, Clare L.
    Redmond, Niamh M.
    Peters, Tim J.
    Clarke, Shane
    Shepstone, Lee
    Lenaghan, Elizabeth
    Shaw, Alison R. G.
    FAMILY PRACTICE, 2012, 29 (02) : 235 - 242
  • [23] EMAS position statement: Bone densitometry screening for osteoporosis
    Brincat, Mark
    Calleja-Agius, Jean
    Erel, C. Tamer
    Gambacciani, Marco
    Lambrinoudaki, Irene
    Moen, Mette H.
    Schenck-Gustafsson, Karin
    Tremollieres, Florence
    Vujovic, Svetlana
    Rees, Margaret
    Rozenberg, Serge
    MATURITAS, 2011, 68 (01) : 98 - 101
  • [24] Optimizing osteoporosis management: targeting to treat - an initiative by the Egyptian Academy of Bone Health
    El Miedany, Yasser
    Gadallah, Naglaa Ali
    Toth, Mathias
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2022, 49 (01)
  • [25] Optimizing osteoporosis management: targeting to treat — an initiative by the Egyptian Academy of Bone Health
    Yasser El Miedany
    Naglaa Ali Gadallah
    Mathias Toth
    Egyptian Rheumatology and Rehabilitation, 2022, 49
  • [26] Update on the utility of trabecular bone score (TBS) in clinical practice for the management of osteoporosis: a systematic review by the Egyptian Academy of Bone and Muscle Health
    El Miedany, Yasser
    Elwakil, Walaa
    Abu-Zaid, Mohammed Hassan
    Mahran, Safaa
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2024, 51 (01)
  • [27] Osteoporosis clinical practice guideline: romosozumab for treating severe osteoporosis - an update by the Egyptian Academy of Bone Health
    El Miedany, Yasser
    Gadallah, Naglaa Ali
    Toth, Mathias
    Hassan, Waleed
    Elgaafary, Maha
    Hassan, Mohamed
    Eissa, Mervat
    Saber, Sally
    Elwakil, Walaa
    Mahran, Safaa
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2022, 49 (01)
  • [28] Osteoporosis clinical practice guideline: romosozumab for treating severe osteoporosis – an update by the Egyptian Academy of Bone Health
    Yasser El Miedany
    Naglaa Ali Gadallah
    Mathias Toth
    Waleed Hassan
    Maha Elgaafary
    Mohamed Hassan
    Mervat Eissa
    Sally Saber
    Walaa Elwakil
    Safaa Mahran
    Egyptian Rheumatology and Rehabilitation, 2022, 49
  • [29] The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
    Siris, E. S.
    Adler, R.
    Bilezikian, J.
    Bolognese, M.
    Dawson-Hughes, B.
    Favus, M. J.
    Harris, S. T.
    Jan de Beur, S. M.
    Khosla, S.
    Lane, N. E.
    Lindsay, R.
    Nana, A. D.
    Orwoll, E. S.
    Saag, K.
    Silverman, S.
    Watts, N. B.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (05) : 1439 - 1443
  • [30] The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
    E. S. Siris
    R. Adler
    J. Bilezikian
    M. Bolognese
    B. Dawson-Hughes
    M. J. Favus
    S. T. Harris
    S. M. Jan de Beur
    S. Khosla
    N. E. Lane
    R. Lindsay
    A. D. Nana
    E. S. Orwoll
    K. Saag
    S. Silverman
    N. B. Watts
    Osteoporosis International, 2014, 25 : 1439 - 1443